Drug Shortage Report for TARO-CARBAMAZEPINE

Last updated on 2019-02-04 History
Report ID 22252
Drug Identification Number 02367394
Brand name TARO-CARBAMAZEPINE
Common or Proper name TARO CARBAMAZEPINE
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) CARBAMAZEPINE
Strength(s) 100MG
Dosage form(s) SUSPENSION
Route of administration ORAL
Packaging size 450 ML
ATC code N03AF
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-10-29
Estimated end date 2018-12-14
Actual end date 2018-11-13
Shortage status Resolved
Updated date 2019-02-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2019-02-04 French Compare
v16 2019-02-04 English Compare
v15 2018-10-30 French Compare
v14 2018-10-30 English Compare
v13 2018-10-16 French Compare
v12 2018-10-16 English Compare
v11 2018-08-03 French Compare
v10 2018-08-03 English Compare
v9 2017-11-15 French Compare
v8 2017-11-15 English Compare
v7 2017-11-15 English Compare
v6 2017-11-03 French Compare
v5 2017-11-03 English Compare
v4 2017-10-02 French Compare
v3 2017-10-02 English Compare
v2 2017-09-18 French Compare
v1 2017-09-18 English Compare

Showing 1 to 17 of 17